Samsung’s expansion plan for its CDMO unit is an efficient, no-nonsense enterprise, marching on with no end in sight. Maybe that’s why, at its home base in South Korea, Samsung Biologics refers to its ...

Samsung is proceeding with an investment in Averr BioTechnology (Averr Bio), a U.S.-based biotech company specializing in gene-editing technology. The move aims to explore high-growth new business ...

Samsung hopes to pave the way for smaller, more-efficient wearables with more capability than ever by shipping the industry's first integrated bio-processor. Share on Facebook (opens in a new window) ...

As South Korea increases its stakes on the “bioeconomy” as its next growth engine and as its “second semiconductor industry,” leading domestic biologic and biosimilar drug producers such as Samsung ...

A couple weeks ago Samsung affirmed its ongoing commitment to the digital health space with the release of the Bio-Processor. The Bio-Processor is a single, compact chip that is capable of measuring ...

Samsung Bioepis Holdings' subsidiaries Samsung Bioepis and Samsung Biologics will sponsor the training of Korea's delegation to the International Biology Olympiad (IBO). Samsung Bioepis and Samsung ...